• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精相关肝病死亡率与二级保健错失机会:英国回顾性观察研究。

Alcohol-related liver disease mortality and missed opportunities in secondary care: A United Kingdom retrospective observational study.

机构信息

Nottingham Digestive Diseases Biomedical Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.

NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.

出版信息

Drug Alcohol Rev. 2022 Sep;41(6):1331-1340. doi: 10.1111/dar.13482. Epub 2022 May 31.

DOI:10.1111/dar.13482
PMID:35640649
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9541852/
Abstract

INTRODUCTION

Alcohol-related liver disease (ARLD) is a preventable cause of mortality. Historical epidemiological studies on ARLD often lack a detailed linked assessment of health-related contacts prior to death which limits understanding of opportunities for intervention. We aimed to analyse retrospective population-based data of all adult residents of Nottinghamshire dying from ARLD to determine the factors associated with delayed diagnosis of ARLD and the potential missed opportunities for interventions.

METHODS

We linked the Office for National Statistics and Hospital Episode Statistics databases to identify adult (≥18 years) residents of Nottinghamshire, who died of ARLD over the 5-year period (1 January 2012 to 31 December 2017). Death was used as the primary outcome, and logistic regression analysis was conducted to test the association between key variables and mortality due to ARLD.

RESULTS

Over 5 years, 799 ARLD deaths were identified. More than half had no diagnosis or a diagnosis of ARLD less than 6 months before death. Emergency presentation at first ARLD diagnosis and White ethnicity were significantly associated with a delay in diagnosis. Overall, the cohort had a median of five hospital admissions, four accident and emergency attendances and 16 outpatient appointments in the 5 years before death. Treatment was provided by a range of specialities, with general medicine the most common. Alcohol was associated with most admissions.

DISCUSSION AND CONCLUSIONS

This study identified deficiencies in ARLD secondary care and provides us with a powerful methodology that can be used to evaluate and improve how alcohol issues are managed and where action can be best targeted.

摘要

引言

酒精性肝病(ARLD)是可预防的死亡原因。关于 ARLD 的历史流行病学研究通常缺乏对死亡前与健康相关的接触的详细链接评估,这限制了对干预机会的理解。我们旨在分析诺丁汉郡所有死于 ARLD 的成年居民的回顾性基于人群的数据,以确定与 ARLD 诊断延迟相关的因素以及潜在的错失干预机会。

方法

我们将国家统计局和医院入院统计数据库链接起来,以确定诺丁汉郡在 5 年内(2012 年 1 月 1 日至 2017 年 12 月 31 日)死于 ARLD 的成年(≥18 岁)居民。死亡被用作主要结局,我们进行了逻辑回归分析,以检验关键变量与 ARLD 死亡率之间的关联。

结果

在 5 年期间,确定了 799 例 ARLD 死亡。超过一半的人在死亡前没有诊断或诊断为 ARLD 不到 6 个月。首次 ARLD 诊断时的紧急就诊和白人种族与诊断延迟显著相关。总体而言,该队列在死亡前的 5 年内中位数有 5 次住院、4 次急诊就诊和 16 次门诊预约。治疗由一系列专科提供,其中普通医学最常见。酒精与大多数入院有关。

讨论和结论

本研究确定了 ARLD 二级保健的不足,并为我们提供了一种强大的方法,可用于评估和改进如何管理酒精问题以及可以在哪里将行动的目标对准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5872/9541852/6db804117c61/DAR-41-1331-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5872/9541852/6db804117c61/DAR-41-1331-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5872/9541852/6db804117c61/DAR-41-1331-g001.jpg

相似文献

1
Alcohol-related liver disease mortality and missed opportunities in secondary care: A United Kingdom retrospective observational study.酒精相关肝病死亡率与二级保健错失机会:英国回顾性观察研究。
Drug Alcohol Rev. 2022 Sep;41(6):1331-1340. doi: 10.1111/dar.13482. Epub 2022 May 31.
2
The impact of alcohol care teams on emergency secondary care use following a diagnosis of alcoholic liver disease - a national cohort study.酒精护理团队对酒精性肝病诊断后急诊二级护理使用的影响——一项全国队列研究。
BMC Public Health. 2016 Aug 2;16:685. doi: 10.1186/s12889-016-3350-0.
3
Outcomes of first emergency admissions for alcohol-related liver disease in England over a 10-year period: retrospective observational cohort study using linked electronic databases.10 年间英国首次因酒精性肝病急诊入院的结局:使用电子数据库链接进行的回顾性观察性队列研究。
BMJ Open. 2023 Nov 22;13(11):e076955. doi: 10.1136/bmjopen-2023-076955.
4
Healthcare interactions prior to first hospital admission with alcohol-related liver disease.首次因酒精性肝病住院前的医疗保健交互作用。
Liver Int. 2024 Sep;44(9):2273-2281. doi: 10.1111/liv.15969. Epub 2024 May 21.
5
Is there scope to improve the selection of patients with alcohol-related liver disease for referral to secondary care? A retrospective analysis of primary care referrals to a UK liver centre, incorporating simple blood tests.是否有改善将酒精相关肝病患者转诊至二级保健的选择范围的空间?对英国肝脏中心初级保健转诊的回顾性分析,纳入了简单的血液检测。
BMJ Open. 2021 Jun 4;11(6):e047786. doi: 10.1136/bmjopen-2020-047786.
6
The Liverpool alcohol-related liver disease algorithm identifies twice as many emergency admissions compared to standard methods when applied to Hospital Episode Statistics for England.与标准方法相比,当将利物浦酒精性肝病算法应用于英格兰的医院入院统计数据时,其识别出的急诊入院人数增加了一倍。
Aliment Pharmacol Ther. 2023 Feb;57(4):368-377. doi: 10.1111/apt.17307. Epub 2022 Nov 17.
7
Incidence and management patterns of alcohol-related liver disease in Korea: a nationwide standard cohort study.韩国酒精相关性肝病的发病和管理模式:一项全国性标准队列研究。
Sci Rep. 2021 Mar 23;11(1):6648. doi: 10.1038/s41598-021-86197-z.
8
Universal screening for alcohol misuse in acute medical admissions is feasible and identifies patients at high risk of liver disease.普遍性筛检急性住院病人之酒精滥用是可行的,并可找出有罹病高风险的肝病患者。
J Hepatol. 2017 Sep;67(3):559-567. doi: 10.1016/j.jhep.2017.04.017. Epub 2017 Jul 27.
9
Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH.酒精性肝病。临床实践指南。由AEEH赞助的共识文件。
Gastroenterol Hepatol. 2019 Dec;42(10):657-676. doi: 10.1016/j.gastrohep.2019.09.006. Epub 2019 Nov 23.
10
How I treat… alcohol-related liver disease.我如何治疗…酒精性肝病。
Clin Med (Lond). 2019 Jan;19(1):43-46. doi: 10.7861/clinmedicine.19-1-43.

引用本文的文献

1
Enhancing opportunities to reduce escalation to substance use disorders through early engagement: a retrospective observational data linkage study of primary and secondary care in Wales.通过早期干预增加减少物质使用障碍升级的机会:威尔士初级和二级医疗保健的回顾性观察数据关联研究
BMJ Public Health. 2025 Jul 13;3(2):e002369. doi: 10.1136/bmjph-2024-002369. eCollection 2025.
2
Screening for Alcohol Use Disorder Among Hospitalised Patients: Learning from a Retrospective Cohort Study in Secondary Care.住院患者酒精使用障碍的筛查:从二级医疗中的一项回顾性队列研究中汲取经验
J Clin Med. 2024 Dec 13;13(24):7617. doi: 10.3390/jcm13247617.
3

本文引用的文献

1
The Effect of Covid-19 on Alcohol Use Disorder and the Role of Universal Alcohol Screening in an Inpatient Setting: A Retrospective Cohort Control Study.Covid-19 对酒精使用障碍的影响及在住院环境中进行普遍酒精筛查的作用:一项回顾性队列对照研究。
Alcohol Alcohol. 2022 Mar 12;57(2):203-210. doi: 10.1093/alcalc/agab059.
2
Late diagnosis of chronic liver disease in a community cohort (UK biobank): determinants and impact on subsequent survival.社区队列中慢性肝病的迟诊(英国生物库):决定因素及其对后续生存的影响。
Public Health. 2020 Oct;187:165-171. doi: 10.1016/j.puhe.2020.07.017. Epub 2020 Sep 28.
3
Validity of administrative codes associated with cirrhosis in Sweden.
Understanding the challenges of identifying, supporting, and signposting patients with alcohol use disorder in secondary care hospitals, post COVID-19: a qualitative analysis from the North East and North Cumbria, England.
理解在新冠疫情后,在二级保健医院中识别、支持和为酒精使用障碍患者提供转介服务所面临的挑战:来自英格兰东北部和北坎布里亚的定性分析。
BMC Health Serv Res. 2024 Jul 1;24(1):772. doi: 10.1186/s12913-024-11232-4.
4
Metformin-Associated Lactic Acidosis in a Diabetic Patient with Normal Kidney Function and Occult Cirrhosis.一名肾功能正常但隐匿性肝硬化的糖尿病患者发生的二甲双胍相关性乳酸性酸中毒。
Case Rep Crit Care. 2022 Oct 5;2022:5506744. doi: 10.1155/2022/5506744. eCollection 2022.
瑞典与肝硬化相关的行政编码的有效性。
Scand J Gastroenterol. 2020 Oct;55(10):1205-1210. doi: 10.1080/00365521.2020.1820566. Epub 2020 Sep 22.
4
ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies.ICD-10-AM 编码用于肝硬化及相关并发症:人群和医疗保健研究的关键绩效考量。
BMJ Open Gastroenterol. 2020 Sep;7(1). doi: 10.1136/bmjgast-2020-000485.
5
Alcohol care teams: where are we now?酒精护理团队:我们现在处于什么状况?
Frontline Gastroenterol. 2019 Aug 14;11(4):293-302. doi: 10.1136/flgastro-2019-101241. eCollection 2020.
6
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK.不可接受的失败:英国柳叶刀委员会关于肝脏疾病的最终报告。
Lancet. 2020 Jan 18;395(10219):226-239. doi: 10.1016/S0140-6736(19)32908-3. Epub 2019 Nov 29.
7
Treating alcohol-related liver disease from a public health perspective.从公共卫生角度治疗酒精相关肝病。
J Hepatol. 2019 Feb;70(2):223-236. doi: 10.1016/j.jhep.2018.10.036.
8
Local care and treatment of liver disease (LOCATE) - A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care.本地化肝病诊治(LOCATE)- 一项旨在初级保健中发现、评估和管理早期肝病的聚类随机可行性研究。
PLoS One. 2018 Dec 21;13(12):e0208798. doi: 10.1371/journal.pone.0208798. eCollection 2018.
9
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease.欧洲肝脏研究学会临床实践指南:酒精性肝病的管理
J Hepatol. 2018 Jul;69(1):154-181. doi: 10.1016/j.jhep.2018.03.018. Epub 2018 Apr 5.
10
Delivering alcohol Identification and Brief Advice (IBA) in housing settings: A step too far or opening doors?在住房环境中提供酒精识别与简短干预建议(IBA):是做得太过还是打开了一扇门?
Drugs (Abingdon Engl). 2016 Sep 2;23(5):365-373. doi: 10.1080/09687637.2016.1176992. Epub 2016 May 16.